{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:04:18Z","timestamp":1792728258068,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T00:00:00Z","timestamp":1710460800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jgar.2024.03.003","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T23:52:33Z","timestamp":1710978753000},"page":"86-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Simultaneous post-neurosurgical ventriculitis and bacteraemia by two different strains of KPC-producing K. pneumoniae successfully treated with meropenem\/vaborbactam and high dose of fosfomycin"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2610-8768","authenticated-orcid":false,"given":"Lorenzo","family":"Volpicelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cairoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6277-5464","authenticated-orcid":false,"given":"Dania","family":"Al Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floriana","family":"Baisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9933-3240","authenticated-orcid":false,"given":"Bianca Maria","family":"Goffredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Venditti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0832-7975","authenticated-orcid":false,"given":"Alessandra","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jgar.2024.03.003_bib0001","doi-asserted-by":"crossref","first-page":"dlac121","DOI":"10.1093\/jacamr\/dlac121","article-title":"Effect of ceftazidime\/avibactam plus fosfomycin combination on 30 day mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae: results from a multicentre retrospective study","volume":"4","author":"Oliva","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.jgar.2024.03.003_bib0002","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jgar.2023.03.012","article-title":"Ceftazidime\/avibactam-resistant meropenem-susceptible KPC-producing Klebsiella pneumoniae: analysis of cases and evaluation of in vitro activity of fosfomycin-containing combinations","volume":"33","author":"Oliva","year":"2023","journal-title":"J Glob Antimicrob Resist"},{"issue":"5","key":"10.1016\/j.jgar.2024.03.003_bib0003","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00079-17","article-title":"In vitro selection of meropenem resistance among ceftazidime-avibactam-resistant, meropenem-susceptible Klebsiella pneumoniae isolates with variant KPC-3 carbapenemases","volume":"61","author":"Shields","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"10.1016\/j.jgar.2024.03.003_bib0004","doi-asserted-by":"crossref","first-page":"ofad327","DOI":"10.1093\/ofid\/ofad327","article-title":"Clinical characteristics and outcome of ceftazidime\/avibactam-resistant Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae infections: a retrospective, observational, 2-center clinical study","volume":"10","author":"Oliva","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"10.1016\/j.jgar.2024.03.003_bib0005","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3390\/antibiotics10070781","article-title":"Synergistic meropenem\/vaborbactam plus fosfomycin treatment of KPC producing K. pneumoniae septic thrombosis unresponsive to ceftazidime\/avibactam: from the bench to the bedside","volume":"10","author":"Oliva","year":"2021","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.jgar.2024.03.003_bib0006","doi-asserted-by":"crossref","first-page":"dlac022","DOI":"10.1093\/jacamr\/dlac022","article-title":"Compassionate use of meropenem\/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study","volume":"4","author":"Tumbarello","year":"2022","journal-title":"JAC Antimicrob Resist"},{"issue":"7","key":"10.1016\/j.jgar.2024.03.003_bib0007","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/14787210.2020.1754193","article-title":"Intravenous fosfomycin for the treatment of patients with central nervous system infections: evaluation of the published evidence","volume":"18","author":"Tsegka","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"1","key":"10.1016\/j.jgar.2024.03.003_bib0008","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1186\/s13054-016-1523-y","article-title":"Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study","volume":"20","author":"Blassmann","year":"2016","journal-title":"Crit Care"},{"key":"10.1016\/j.jgar.2024.03.003_bib0009","doi-asserted-by":"crossref","first-page":"1048653","DOI":"10.3389\/fphar.2022.1048653","article-title":"Cerebrospinal fluid concentrations of fluoroquinolones and carbapenems in tuberculosis meningitis","volume":"13","author":"Maranchick","year":"2022","journal-title":"Front Pharmacol"},{"issue":"9","key":"10.1016\/j.jgar.2024.03.003_bib0010","doi-asserted-by":"crossref","first-page":"ofaa349","DOI":"10.1093\/ofid\/ofaa349","article-title":"Using therapeutic drug monitoring to treat KPC-producing Klebsiella pneumoniae central nervous system infection with ceftazidime\/avibactam","volume":"7","author":"Yasmin","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jgar.2024.03.003_bib0011","doi-asserted-by":"crossref","first-page":"e00963","DOI":"10.1016\/j.idcr.2020.e00963","article-title":"Carbapenemase producing Klebsiella pneumoniae (KPC) meningitis from chronic otitis media","volume":"22","author":"Anwar","year":"2020","journal-title":"IDCases"},{"key":"10.1016\/j.jgar.2024.03.003_bib0012","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.ijid.2022.07.073","article-title":"A post-neurosurgical infection due to KPC-producing Klebsiella pneumoniae treated with meropenem-vaborbactam: a case report","volume":"122","author":"Choi","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"8","key":"10.1016\/j.jgar.2024.03.003_bib0013","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1093\/jac\/dkz156","article-title":"KPC-31 expressed in a ceftazidime\/avibactam-resistant Klebsiella pneumoniae is associated with relevant detection issues","volume":"74","author":"Antonelli","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jgar.2024.03.003_bib0014","unstructured":"EUCAST European Committee on antimicrobial susceptibility testing Website. Clinical breakpoints - breakpoints and guidance January 2, 2023. Clinical breakpoints (v 13.1)-new file for printing (29 June 2023) to make new breakpoints for anaerobic bacteria available. https:\/\/www.eucast.org\/clinical_breakpoints. [accessed 22.07.2023]."},{"key":"10.1016\/j.jgar.2024.03.003_bib0015","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2147\/IDR.S326456","article-title":"Current perspectives on the diagnosis and management of healthcare-associated ventriculitis and meningitis","volume":"15","author":"Karvouniaris","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2024.03.003_bib0016","doi-asserted-by":"crossref","unstructured":"Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ Infectious Diseases Society of America Antimicrobial-Resistant Treatment Guidance: gram-negative bacterial infections. Infectious Diseases Society of America 2023; Version 3.0. https:\/\/www.idsociety.org\/practice-guideline\/amr-guidance\/. [accessed 22.07.2023].","DOI":"10.1093\/cid\/ciad428"},{"issue":"5","key":"10.1016\/j.jgar.2024.03.003_bib0017","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02497-17","article-title":"Pneumonia and renal replacement therapy are risk factors for ceftazidime-avibactam treatment failures and resistance among patients with carbapenem-resistant Enterobacteriaceae infections","volume":"62","author":"Shields","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2024.03.003_bib0018","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jgar.2021.04.001","article-title":"Resistance to ceftazidime\/avibactam in infections and colonisations by KPC-producing Enterobacterales: a systematic review of observational clinical studies","volume":"25","author":"Di Bella","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"issue":"6","key":"10.1016\/j.jgar.2024.03.003_bib0019","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1093\/cid\/ciw861","article-title":"Infectious Diseases Society of America\u2019s clinical practice guidelines for healthcare-associated ventriculitis and meningitis","volume":"64","author":"Tunkel","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jgar.2024.03.003_bib0020","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1007\/s00701-018-3680-z","article-title":"Intrathecal penetration of meropenem and vancomycin administered by continuous infusion in patients suffering from ventriculitis-a retrospective analysis","volume":"160","author":"Mader","year":"2018","journal-title":"Acta Neurochir (Wien)"},{"issue":"8","key":"10.1016\/j.jgar.2024.03.003_bib0021","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00438-22","article-title":"Meropenem population pharmacokinetics and simulations in plasma, cerebrospinal fluid, and brain tissue","volume":"66","author":"Alshaer","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.jgar.2024.03.003_bib0022","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/jac\/dkh158","article-title":"Concentrations of fosfomycin in the cerebrospinal fluid of neurointensive care patients with ventriculostomy-associated ventriculitis","volume":"53","author":"Pfausler","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"10.1016\/j.jgar.2024.03.003_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106760","article-title":"A novel method to evaluate ceftazidime\/avibactam therapy in patients with carbapenemase-producing Enterobactericeae (CPE) bloodstream infections","volume":"61","author":"Gatti","year":"2023","journal-title":"Int J Antimicrob Agents"},{"issue":"8","key":"10.1016\/j.jgar.2024.03.003_bib0024","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1080\/1120009X.2021.1909939","article-title":"Looking beyond ceftazidime-avibactam resistance in KPC-producing Klebsiella pneumoniae: in vitro activity of the novel meropenem-vaborbactam in combination with the old fosfomycin","volume":"33","author":"Boattini","year":"2021","journal-title":"J Chemother"}],"updated-by":[{"DOI":"10.1016\/j.jgar.2024.12.009","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000}}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716524000547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716524000547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T19:04:02Z","timestamp":1731611042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716524000547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":24,"alternative-id":["S2213716524000547"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2024.03.003","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jgar.2024.12.009","asserted-by":"object"}]},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Simultaneous post-neurosurgical ventriculitis and bacteraemia by two different strains of KPC-producing K. pneumoniae successfully treated with meropenem\/vaborbactam and high dose of fosfomycin","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2024.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}